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Abstract: Demographic changes confront clinicians with 
an increasing number of orthogeriatric patients. These 
patients present with comorbidities, which force their sur-
geons to take into consideration their medical condition. 
A major risk factor for fractures in orthogeriatric patients 
is osteoporosis in combination with frailty. To prevent sub-
sequent fractures in these patients, we need to pay atten-
tion to adequate osteoporosis treatment in orthogeriatric 
patients. There is a huge treatment gap. In  Germany, 77% 
of patients with osteoporosis are not treated adequately. 
Even after fragility fractures, a low percentage of patients 
receive a specific osteoporosis therapy. Secondary pre-
vention is of great importance in the treatment of these 
patients. Diagnostics and treatment should be already 
initiated with the admission to the hospital. Treatment 
decisions need to be made individually based on the risk 
profile of the patients. After discharge, it is important to 
involve the patients’ general practitioners and to follow 
up on patients regularly to improve their compliance and 
to ensure adequate therapy. Establishing a fracture liaison 
service helps coordinating osteoporosis treatment during 
hospitalization and after discharge. Subsequent fractures 
can be reduced; therefore, it is an effective service for sec-
ondary prevention. The present article provides an over-
view of how an efficient identification and subsequent 
treatment of osteoporosis can be achieved in aged trauma 
patients.
Keywords: fracture liaison service; hip fracture; orthogeri-
atric; osteoporosis; vitamin D.
Background
Demographic changes confront clinicians with an increas-
ing number of orthogeriatric patients. Aged trauma 
patients present with various comorbidities, and these 
have to be addressed to secure the results of surgical inter-
vention. Thus, fractures associated with a low-energy 
trauma are frequently the first sign indicating an under-
lying osteoporosis [1, 2]. Given the high prevalence of 
osteoporosis in combination with frailty, patients are at a 
high risk for secondary fractures. Within 5 years after an 
osteoporotic index fracture, 14.7% of these patients suffer 
another hip fracture and 32.5% another  osteoporotic 
 fracture [3].
Thus, it is crucial to screen orthogeriatric patients for 
an underlying osteoporosis to initiate adequate therapy, 
adjust the surgical procedures, and prevent subsequent 
fractures in these patients.
Epidemiology
In female patients older than 75 years, the prevalence of 
osteoporosis is 59.2% [4]. Approximately 6.3–7.8  million 
of German inhabitants are affected by osteoporosis [5]. 
However, there is a huge treatment gap, as 77% of these 
patients are not treated adequately [6]. Even after fragil-
ity fractures, only 16%–21% of female patients and 3.4% 
of male patients receive specific osteoporosis therapy [5, 
7]. Given the high risk of secondary osteoporotic fractures, 
prevention is of great importance in the treatment of these 
patients.
Identification
At a first glance, the identification of patients at risk of 
osteoporosis appears complicated. However, there are 
fractures such as thoracic and lumbar vertebral fractures, 
proximal femur fractures, proximal humerus fractures, 
and fractures of the distal radius in which the prevalence 
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of an underlying osteoporosis remains high. Osteoporosis 
was diagnosed in 56.2% of women older than 50 years with 
fragility fractures and men ages 60 years [4]. Patients with 
typical osteoporosis-related fractures should be screened 
for osteoporosis [8].
According to the guidelines for osteoporosis by the 
Dachverband Osteologie e.V. (DVO) 2014, patients without 
any fracture should generally be assessed at the age of 
70 years in women and at the age of 80 years in men; in 
high-risk patients, a clarification in younger age might 
already be useful [9].
When orthogeriatric patients with fractures are 
admitted to hospital, risk factors for osteoporosis should 
be assessed by standardized questionnaires. Thus, 
standardized questionnaires and algorithms based on 
the osteoporosis guidelines of the DVO 2014 for preven-
tion, diagnostics, and treatment of osteoporosis [9] can 
help to estimate the risk of a secondary fracture (down-
loads available at http://www.klinikum.uni-muenchen.
de/Klinik-fuer-Allgemeine-Unfall-und-Wiederherstel-
lungschirurgie/de/fach/alterstraumatologie/downloads/
index.html). Internationally acknowledged to identify 
the osteoporosis-associated fracture risk are the FRAX- or 
Q-factor score [10, 11]. A diagnostic assessment in post-
menopausal women and men older than 60 years is rec-
ommended as soon as a fragility fracture or an increased 
risk of fractures is present [12].
Osteoporosis diagnostics
The new guidelines of the DVO 2014 recommend five diag-
nostic steps to confirm the diagnosis of osteoporosis.
Taking the medical history should already identify 
risk factors for osteoporosis as mentioned above. The fol-
lowing subjects are important to include in the medical 
history: tendency to fall, medication (especially glucocor-
ticoids, aromatase inhibitors, and the long-term intake of 
proton pump inhibitors, which are a potential risk factor 
still under discussion), and preexisting conditions such 
as diabetes mellitus, ankylosing spondylitis, chronic 
obstructive pulmonary disease (COPD), and endocrine 
disorders (such as hypothyroidism).
Also, a detailed clinical examination helps finding 
indicators for osteoporosis. Especially, the Tannenbaum 
phenomenon is common. In addition, a loss of height over 
2 cm may indicate further diagnostics [13].
A basic blood testing consists of calcium and phos-
phate in serum, alkaline phosphatase, γ-glutamyl-
transferase (γ-GT), creatinine, C-reactive protein (CRP), 
thyroid-stimulating hormone (TSH), 25-OH-vitamin D3, a 
serum electrophoresis, and a complete blood count.
Dual X-ray absorptiometry (DXA) is the gold standard 
to determine bone density. Radiation exposure and costs 
are relatively small [8]. The lower bone density is, the 
higher is the risk for osteoporotic fractures [14]. Density 
measurements of the lumbar spine, femur, and femoral 
neck are set in relation to bone density values of a normal 
population (T-value). Treatment is based on the t-value, 
age of patients, and the individual risk factors. Risk 
factors, such as glucocorticoid therapy or multiple frac-
tures in the past 3 years, increase the treatment threshold.
According to the DVO 2014 [9], in some cases, bone 
density scans are not necessary to obtain the diagnosis of 
an underlying osteoporosis. Thus, in patients having suf-
fered a fragility fracture that shows radiographic signs of 
an osteoporosis within the spine or proximal femur (i.e. 
Figures 1 or 2), an underlying osteoporosis can be diag-
nosed without bone density measurements. Also, multi-
ple low-graded fractures of the vertebral spine, such as a 
singular grade II impression of the vertebrae according to 
the Genant classification, go in line with an underlying 
osteoporosis (Figure 1) [15].
Degenerative changes (i.e. of the spine) can increase 
the t-value. If, in these cases, bone density scans of the 
Figure 1: Preoperative CT scan with an atraumatic lumbar vertebral 
fracture.
In this case, the diagnosis of an underlying osteoporosis can be 
secured without further bone density scans.
Unangemeldet
Heruntergeladen am | 05.12.18 14:47
Schray et al.: Diagnosis and therapy of osteoporosis in geriatric trauma patients: an update      67
hip cannot be applied, quantitative computed tomogra-
phy (CT) scans are recommended [16, 17].
Osteoporosis treatment
Vitamin D deficiency is widely spread among elderly 
patients. It is associated with muscle weakness and there-
fore with a tendency to fall. Aged trauma patients are at 
high risk to develop vitamin D deficiency because of mal-
nutrition, reduced sunlight exposure, impaired intestinal 
absorption, and impaired hydroxylation in the liver and 
kidneys [18]. In elderly patients with hip fractures, only 
approximately 10% of the patients have an adequate 
vitamin D level [19].
Treatment algorithms can be helpful for the decision 
of the individual osteoporosis therapy (Figure 3).
Basic treatment aims on a compensation of vitamin D 
level and a sufficient calcium intake. A balanced calcium 
homeostasis is required for the initiation of a specific 
osteoporosis treatment and crucial to secure fracture 
healing [20].
According to the DVO guidelines, a dose of approxi-
mately 1000 IU/day vitamin D is needed to maintain a 
normal to high vitamin D level. Vitamin D application 
should be adjusted to the laboratory results (Table 1). A 
25-OH-vitamin D level above 75 μg/L is not recommended, 
as it has been shown to be associated with an increased 
risk of falls [21].
The intake of calcium should be up to 1000 mg/day. 
Raising the calcium level can be achieved through diet, 
for example, with calcium-rich mineral water (about 
400 mg/L) or dairy products such as milk, cheese, cottage 
cheese, or yogurt. During a therapy with glucocorticoids, 
calcium supplements with a dose of 1000 mg/day calcium 
are recommended.
As supplement, calcium carbonate is recommended. 
However, a high percentage of elderly patients have 
proton pump inhibitors among their daily medication. In 
these patients, calcium citrate or calcium gluconate is rec-
ommended for an adequate resorption of calcium [22].
Depending on laboratory findings, specific therapy 
can be initiated during hospitalization. Considering con-
traindications and comorbidities, a specialized physician 
should initiate specific therapy.
Oral bisphosphonates are the first-line medication 
in postmenopausal osteoporosis. In patients older than 
75 years, alendronate and risedronate show a reduced risk 
for vertebral fractures [23]. Also, intravenously applied 
bisphosphonates such as ibandronate or zolendranate 
show a reduction of vertebral fractures and zolendronate 
also decreases the total fracture risk.
An intravenous therapy with bisphosphonates should 
not be started before 14  days after surgery to prevent 
accumulation around the internal fixation [24]. To avoid 
hypocalcemia, vitamin D levels should be normal before 
starting with a specific osteoporosis therapy. In some 
cases, an intravenous bisphosphonate therapy is recom-
mended 6 weeks after fracture.
Studies show that intravenous therapy with bispho-
sphonates is not inferior to the therapy with oral bispho-
sphonates concerning fracture risk. The compliance of 
the patients might be even higher in monthly intravenous 
applications than in taking it orally [25, 26].
The osteoanabolic therapy with recombinant para-
thyroid hormone (teriparatide) is effective but costly. It 
can be an option when, despite adequate pretreatment, 
osteoporosis progresses or causes further vertebral frac-
tures. Teriparatide received the recommendation level B 
of the DVO due to the superior effect compared to alen-
dronate in treating glucocorticoid-induced osteoporosis 
and reducing peripheral postmenopausal osteoporotic 
fractures [27].
Depending on the risk profile of the patient, mono-
clonal antibodies, such as denosumab, are also con-
sidered as an option. Studies with denosumab show a 
reduction of vertebral fractures and peripheral fractures 
such as proximal femur fractures. Especially, in ortho-
geriatric patients with limited compliance associated 
with cognitive disorders such as dementia or patients 
who refuse taking more oral medication, denosumab 
offers advantages. Thus, a specific osteoporosis therapy 
with denosumab, which has to be applied only twice 
a year, can be secured easily, as it is injected subcuta-
neously, which could be handled, for example, by the 
Figure 2: Preoperative X-ray with a pertrochanteric fracture of the 
proximal femur on the left side.
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nursing staff and monitored by their general practition-
ers [28–30].
Due to the increased risk of thrombosis, strontium 
ranelate, selective estrogen receptor modulators (SERMs; 
raloxifene and bazedoxifene), and estrogens (optionally 
in combination with a progestin) are not suitable for 
orthogeriatric patients [10, 31].
Calcitonin plays no role in first-line therapy. Only in 
cases with severe renal insufficiency, it might be applied 
because other agents are contraindicated.
Basic treatment:
Vitamin D3 1000 IU/day
Calcium 1000 IU/day via supplements, if
possible via nutrition






   
Oral bisohosphonates (BP) +  
alendronate 70 mg/week  
concomitant to PPI 
risedronate 35 mg/week +
  
Denosumab***
60 mg sc/6 months
  
Teriparatid** +
20 µg sc/day during 24 months 
BP i.V.











Balanced + rich in calcium
– Mineral water rich in calcium
– 2 slices of hard cheese/day
– Half a liter milk, curds or yoghurt/day
* Main contraindications:
• Gastric or esophageal diseases
• Dysphagia, gastritis, ulcers
• Disability to stand or to sit up straight  
 for 30 min
** Contraindications:
• Hypercalcaemia
• Severe renal failure
• Hyperparathyreoidism
• Paget’s disease
• Skeletal malgnancies or bone metastases
• Status post radiotherapy
*** Prior to Denosumab:
• Hypocalcemia?
• Reconstruction of dental chart
• Vitamin-D supplementation if needed










Figure 3: LMU algorithm for the treatment of osteoporosis.
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Prevention
An effective prevention of subsequent fractures includes 
also fall prevention with muscle training, physiotherapy, 
and critical adjustment of the preexisting medication.
Training should concentrate on an integration 
of general movement, improvement of coordination, 
balance, posture, and flexibility [32].
Medication, which causes vertigo or dizziness, should 
be reduced [33]. Also, medication that reduces bone 
quality (e.g. glucocorticoids) or bone healing [e.g. non-
steroidal antirheumatics (NSAR)] should be avoided.
A big problem is also the compliance of these elderly 
patients. The literature shows that the percentage of com-
pliant patients decreases to 50% over a period of 1 year 
after initiation of treatment and even to only 30% over 
time [34]. Women and patients with DXA were more likely 
to follow their doctors’ instructions, whereas older or 
multimorbid patients and those with a preexisting high 
amount of medications are more likely to not continue 
with their medication.
Secondary prevention via fracture liaison service 
(FLS) is another additional organization to comanage-
ment to reduce subsequent fractures and postopera-
tive complications. First mentioned in 1999, the “UK 
National Health Service” in Glasgow, Scotland, estab-
lished one of the first FLS. Today, clinics can apply to 
certify through the International Osteoporosis Founda-
tion (IOF) for FLS.
A specially trained fragility fracture nurse is taking 
care of the coordination of the patients’ treatment after 
admission to the hospital. Besides identifying patients of 
high risk and initiation of adequate diagnostics and osteo-
porosis therapy, the fragility fracture nurse is also moni-
toring the patients’ compliance after discharge.
This network also increases compliance by close 
 supervision in rehabilitation and outpatient clinics [35, 36].
The rate of subsequent fractures in patients with 
untreated osteoporosis increases significantly within the 
first 2 years after the first fracture [37]. Patients with fragil-
ity fractures have an increased risk of 86% for subsequent 
fractures [38]. In patients with vertebral fractures, the 
risk of another fracture is doubled and after proximal 
femur fractures even trebled [39]. Recent studies show 
that establishing an FLS can reduce subsequent fractures 
by approximately 30%. Axelsson et al. stated that even a 
minimal resource FLS was effective in increasing inves-
tigation and treatment (Figure 4). Patients treated in an 
FLS setting had a re-fracture risk reduction of 51%. This 
indicates that an FLS can improve secondary prevention 
of fractures [40, 41].
To prevent one re-fracture in 3  years, the number 
needed to treat (NNT) with FLS is 20 [42]. For the widely 
spread angiotensin-converting enzyme (ACE) inhibitors 
and angiotensin receptor blockers (ARBs), the NNT is 80 
and 338 over a period of 4.3 years to prevent one myocar-
dial infarction.
Allowing an early initiation of appropriate treatment, 
the rate of subsequent fracture can be significantly reduced 
[41, 43]. Another positive effect lays in the reduction of 
Table 1: Vitamin D3 levels and treatment recommendations adapted from Amling [20].
  25-OH-vitamin 
D3 level, mg/L
  Cholecalciferol   Comments
Severe deficiency   < 10  20,000 IU/day for 10 days then 20,000 IE/week  Additional tests for calcium metabolism
Distinct deficiency   10–20  20,000 IU/day for 5 days then 20,000 IE/week   Follow up after 2–3 months
Deficiency   21–30  20,000 IU/week   Follow up after 2–3 months
Optimal level   31–60  1000–2000 IU/day   Maintain level
Oversupply   > 100  Pause therapy   Addressing causes
Figure 4: Re-fracture rate with and without treatment of osteoporo-
sis in an FLS setting from 2011 to 2014 [40].
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health economic cost [44, 45]. The literature shows that 
introducing an orthogeriatrician-led or a nurse-led FLS is 
cost-effective compared to usual care.
Conclusion
The management of orthogeriatric patients should not 
only focus on the surgical aspects of treatment but also 
include diagnosis and treatment of an underlying osteo-
porosis. Decisions should be based on the risk profile of 
the patients. Treatment is more complicated because of 
comorbidities limiting the therapy options. It is also dif-
ficult to convince these patients to follow through with 
their therapy even if they have already reached a high 
age. Therefore, it is important to involve their general 
practitioners and the patients themselves as an attempt 
to increase compliance. Thus, precise patient informa-
tion about their therapy and risk of subsequent fractures 
is of importance. Especially, aged trauma patients tend to 
concentrate on their return to daily activities following 
fracture and neglect the necessity of osteoporosis therapy. 
Therefore, it is important to follow up on these patients 
and secure secondary fracture prevention.
FLS is a new approach that can significantly increase 
the efficiency of osteoporosis treatment by coordinating 
osteoporosis treatment during hospitalization and after 
discharge. It helps avoiding subsequent fractures and 
therefore is an effective service to secure secondary frac-
ture prevention.
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How adequate is the data presentation? 4
Are units and terminology used correctly? 3
Is the number of cases adequate? N/A
Are the experimental methods/clinical studies adequate? N/A
Is the length appropriate in relation to the content? 4
Does the reader get new insights from the article? 4
Please rate the practical significance. 5 - High/Yes
Please rate the accuracy of methods. N/A
Please rate the statistical evaluation and quality control. N/A
Please rate the appropriateness of the figures and tables. 3
Please rate the appropriateness of the references. 4
Please evaluate the writing style and use of language. 3
Please judge the overall scientific quality of the manuscript. 4
Are you willing to review the revision of this manuscript? Yes 
Comments to Authors:
 ©2016 Neuerburg C. et al., published by De Gruyter.  
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License. Unangemeldet
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Reviewer Recommendation Term: Revise with Major Modifications
Overall Reviewer Manuscript Rating: 70
Custom Review Questions Response
Is the subject area appropriate for you? 5 - High/Yes
Does the title clearly reflect the paper’s content? 3
Does the abstract clearly reflect the paper’s content? 3
Do the keywords clearly reflect the paper’s content? 4
Does the introduction present the problem clearly? 3
Are the results/conclusions justified? 3
How comprehensive and up-to-date is the subject matter presented? 4
How adequate is the data presentation? 3
Are units and terminology used correctly? 5 - High/Yes
Is the number of cases adequate? N/A
Are the experimental methods/clinical studies adequate? N/A
Is the length appropriate in relation to the content? 3
Does the reader get new insights from the article? 3
Please rate the practical significance. 4
Please rate the accuracy of methods. 3
Please rate the statistical evaluation and quality control. N/A
Please rate the appropriateness of the figures and tables. 3
Please rate the appropriateness of the references. 4
Please evaluate the writing style and use of language. 2
Please judge the overall scientific quality of the manuscript. 3
Are you willing to review the revision of this manuscript? Yes 
Comments to Authors:
Dear Authors, 
your Article „Diagnostic and therapy of osteoporosis in geriatric Trauma patients“ presents a really good overview in a Topic, which is 
very important already and will me even more important in the future. I believe, your article will help Trauma surgeons, who are involved 
in the Treatment of geriatric Trauma patients. Osteoporosis is one of the Major Problems in patients healthcare, especially in Trauma 
surgery.
Nevertheless, I have some minor Points for Revision: 
- Abstract: FLS appears for the first time. Therefore it has to be written in full lenght 
- Osteoporosis diagnsotics; Line 56: Some in vitro studies reported, that there was no adversed effect of PPI on human osteoblasts 
(Prause, M et al. Injury 2014; Prause, M et al. Mediators inflamm 2015). Therefore it remains unclear, if PPI are associated with a higher 
fracture risk.  
- Figure 3: There are two speech bubbles. I can‘t find any Information in them. 
- Figure 3: One box is written in German 
- Site 10 Line 192: ...Treatment an even; does it mean:... Treatment and even 
- Site 10 Line 197,198: The Fracture Liaison Service.... This is a final Statement. You should not start your paragraph about FLS with a final 
Statement. This should be at the end.
In General:
- Was the manuscript reviewed by a native Speaker? It might benefit from language Support. 
- All figures and tables are not cited in the text. It is important to cite them in the text. 
- Our patients might benefit from a FLS. In Germany, such a Service is not payed by the public health insurance, currently. I think, this is 
another great Problem. Who has to pay the costs of secondary prevention? 
- Your presented algorithm for Treatment of osteoporosis is really impressive. I think in a Center for geriatric Trauma with geriatricians, such 
a algorithm is very good. But in a Standard Trauma department without geriatric Support, i think there are some risks like contraindications, 
medical interactions ect. Basic Treatment with Vitamin D and Calcium is no Problem and should be started, when osteoporosis is diagnosed. 
But Specific medical treatment should be given by specialized physicians. In our „Alterstraumazentrum“ we have defined that in this way. 
- Patients with distal radius fractures are usually hospitalized for only one or two days. Therefore we have to built Networks, to treat their 
osteoporosis. In These cases the time is to short for your algorithm
Reviewer 2: Peter Giannoudis
Nov 28, 2016
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This is an interesting article. The topic is relevant. However, the manuscript can be improved further by: 
 
1. The language being checked by a native English speaker.  
2. Title should be revised 
3. Back ground: further information is required i.e.: (that usually the underlying osteoporosis condition is overlooked. There are issues 
not only how to fix the fractures because of the compromised bone but also to ensure that we can influence prevention of further frac-
tures.. Appropriate references must be used). 
4. A special paragraph should be inserted to address the fact that 30-40% of elderly patients admitted are with dementia. Specific in-
structions as to how these patients should be assessed  
and managed should be included.  
5. Please see below some comments: 
 
Title: Diagnostic and therapy of osteoporosis in geriatric trauma patients 
 
Revise to: Diagnosis and treatment of osteoporosis in geriatric trauma patients: An update 
 
Sentence 5:…. These patients present with comorbidities, which forces their surgeons to take into consideration their medical condition. 
 
Sentence 14: However, there is a huge treatment gap as 77% of these patients are not treated adequately (3). 
 
Sentence 23: At a first glance, the identification of patients at risk of osteoporosis appears complicated. 
 
Sentence 41:….. (7) help estimating the fracture risk. These algorithms can be accessed on our 42 homepage (8). 
 
Please move reference 8 next to 7 to read as follows:….. (7, 8) help estimating the fracture risk.  
 
Sentence 60: Especially the Tannenbaum phenomenon is an indicator of bone loss and also a loss of height more than 2cm may indicate 
further diagnostics. Please insert reference.  
 
Sentence 68:… The lower bone density the higher is the risk for osteoporotic fractures (13). 
Should be: The lower the bone density is the higher would be the risk for osteoporotic fractures (13). 
 
Sentence 74-75: …. According to the DVO guideline 2014 (7) patients having suffered a trochanteric fracture which is suspicious for an 
osteoporosis given the radiographic… 
Should be: According to the DVO guideline 2014 (7) patients having suffered a trochanteric fracture which is suspicious for osteoporosis 
given the radiographic… 
 
Sentence 76: ….which is associated with a low energy trauma no further bone density 
Should be: …which is associated with a low energy trauma no bone density… 
 
Sentence 79:…. Genant classification go inline Please insert reference. 
 
Sentence 105: Title: Treatment of osteoporosis in stationary trauma 
Comment: Stationary trauma not appropriate word!! You mean following low velocity trauma? 
 
Sentence 170: ..Their general practitioners can monitor patients with dementia or patients who refuse taking more oral medication, appli-
cation is only necessary twice a year (25-27). 
 
Revise to: Patient with dementia or patients who refuse taking more oral medication can be monitored by their general practitioners,
application is only necessary twice a year.  
 
Sentence 192:……. an even to only 30% over time (29). 
Revise …and even to only 30% over time (29). 
 
Sentence 243: Orthogeriatric patients challenge their physicians to include their special needs in the treatment. It is important to not only 
concentrate on the surgical treatment but to 
address osteoporosis its diagnostic and its treatment especially to avoid subsequent 
fractures. 
Revise: Management of Orthogeriatric patients not only should be focused on the surgical aspects of treatment but also should include 
diagnosis and treatment of the underlying osteoporosis 
 
Please revise and resubmit.
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Authors’ Response to Reviewer Comments
Dec 05, 2016
Dear Reviewers,  
 
The authors would like to thank you for having reviewed our manuscript “Diagnosis and therapy of osteoporosis in geriatric trauma 
patients: An update”.  
We appreciate the additional perspective that you provided.  
 
We appreciate the comments of all Reviewers and we tried to integrate your suggestions in our article.  
 
Please find below our responses to the Reviewers’ comments. Changes to the manuscript have been made according to the Reviewers’ 
suggestions and are highlighted using “Track Changes”.  
 
The manuscript was checked by a native speaker with regards to language editing.  
 
Ad Reviewer #1:  
Osteoporosis diagnsotics; Line 56: Some in vitro studies reported, that there was no adversed effect of PPI on human osteoblasts (Prause, 
M et al. Injury 2014; Prause, M et al. Mediators inflamm 2015). Therefore it remains unclear, if PPI are associated with a higher fracture 
risk.  
Response:  
Literature shows differing conclusions, but a number of studies are showing consistent results that support the conclusion that there 
might be long-term adverse effects. You are right it remains unclear, but PPI prescriptions are high in this age group and should at least be 
reconsidered.  
 
Our patients might benefit from a FLS. In Germany, such a Service is not payed by the public health insurance, currently. I think, this is 
another great Problem. Who has to pay the costs of secondary prevention?  
Response:  
This is an interesting aspect. The focus of public health insurance is slowly shifting towards prevention. Small hospitals might have prob-
lems organizing and financing an FLS. Future models of an integrated care or Best practice tariffs might serve as an incentive for improved 
secondary fracture prevention. Yet, we refrained from stressing the financial burden of the FLS within the manuscript to avoid confusion. 
However, monitoring of these patients should be integrated in general checkups and surgical follow-ups.  
 
 
Your presented algorithm for Treatment of osteoporosis is really impressive. I think in a Center for geriatric Trauma with geriatricians, such 
a algorithm is very good. But in a Standard Trauma department without geriatric Support, i think there are some risks like contraindica-
tions, medical interactions ect. Basic Treatment with Vitamin D and Calcium is no Problem and should be started, when osteoporosis is 
diagnosed. But Specific medical treatment should be given by specialized physicians. In our “Alterstraumazentrum” we have defined that 
in this way.  
 
Patients with distal radius fractures are usually hospitalized for only one or two days. Therefore we have to build Networks, to treat their 
osteoporosis. In These cases the time is too short for your algorithm.  
Response:  
This is an important aspect that you are mentioning. In our center, the fragility fracture nurse and a geriatrician monitor the treatment 
of our patients. Therapy is initiated during the hospital stay or during close follow-ups at our outpatient clinic. A recommendation for 
adequate medication is mentioned in our discharge letter. It is important to raise patients’ awareness for osteoporosis, to start with basic 
medication and to follow up in order to adjust the current medication and add specific medication.  
We start our algorithm with the patient’s admission to our hospital and depending on their stay we add recommendations for diagnostics
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 or adequate medication to our discharge letter. We also suggest appointments to follow up. In order to monitor these patients closely we 
need to establish networks that improve the compliance of these patients.  
 
Ad Reviewer #2:  
 
A special paragraph should be inserted to address the fact that 30-40% of elderly patients admitted are with dementia. Specific instruc-
tions as to how these patients should be assessed and managed should be included.  
Response:  
You are absolutely right. We tried to integrate treatment advices in our article, especially concerning the intake of medication.  
Patients with dementia are more likely to fall and suffer subsequent fractures, therefore it is important to treat osteoporosis adequately. 
Daily intake of medication is difficult; we therefore recommend medication that is only applied monthly or twice a year. In order to 
monitor these patients a close network with their family doctors is very important. As an attempt to indicate the problem of cognitive 
disorders alternative osteoporosis treatment was mentioned within the manuscript.  
 




Reviewers’ Comments to Revision 
Reviewer 1: Carsten Schöneberg
Dec 07, 2016
Reviewer Recommendation Term: Accept
Overall Reviewer Manuscript Rating: 65
Custom Review Questions Response
Is the subject area appropriate for you? 4
Does the title clearly reflect the paper’s content? 5 - High/Yes
Does the abstract clearly reflect the paper’s content? 5 - High/Yes
Do the keywords clearly reflect the paper’s content? 3
Does the introduction present the problem clearly? 4
Are the results/conclusions justified? 4
How comprehensive and up-to-date is the subject matter presented? 4
How adequate is the data presentation? 4
Are units and terminology used correctly? 3
Is the number of cases adequate? N/A
Are the experimental methods/clinical studies adequate? N/A
Is the length appropriate in relation to the content? 4
Does the reader get new insights from the article? 4
Please rate the practical significance. 5 - High/Yes
Please rate the accuracy of methods. N/A
Please rate the statistical evaluation and quality control. N/A
Please rate the appropriateness of the figures and tables. 4
Please rate the appropriateness of the references. 4
Please evaluate the writing style and use of language. 4
Please judge the overall scientific quality of the manuscript. 4
Are you willing to review the revision of this manuscript? Yes 
Comments to Authors:
Dear Authors, 
the manuscript benefits from the changes you made. Now, i can accept the manuscript for publication.
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Reviewer 2: Peter Giannoudis
Dec 06, 2016
Reviewer Recommendation Term: Accept
Overall Reviewer Manuscript Rating: 80
Custom Review Questions Response
Is the subject area appropriate for you? 5 - High/Yes
Does the title clearly reflect the paper’s content? 5 - High/Yes
Does the abstract clearly reflect the paper’s content? 4
Do the keywords clearly reflect the paper’s content? 5 - High/Yes
Does the introduction present the problem clearly? 4
Are the results/conclusions justified? 4
How comprehensive and up-to-date is the subject matter presented? 4
How adequate is the data presentation? 4
Are units and terminology used correctly? 5 - High/Yes
Is the number of cases adequate? N/A
Are the experimental methods/clinical studies adequate? N/A
Is the length appropriate in relation to the content? 4
Does the reader get new insights from the article? 4
Please rate the practical significance. 5 - High/Yes
Please rate the accuracy of methods. 4
Please rate the statistical evaluation and quality control. N/A
Please rate the appropriateness of the figures and tables. 4
Please rate the appropriateness of the references. 5 - High/Yes
Please evaluate the writing style and use of language. 4
Please judge the overall scientific quality of the manuscript. 4
Are you willing to review the revision of this manuscript? Yes 
Comments to Authors:
There revised paper has been improved. It reads better. It can be accepted now.
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